Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $45.0 million.

  • Rapid Micro Biosystems' Shares Outstanding (Diluted Average) rose 294.83% to $45.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.0 million, marking a year-over-year increase of 294.83%. This contributed to the annual value of $43.6 million for FY2024, which is 128.22% up from last year.
  • Latest data reveals that Rapid Micro Biosystems reported Shares Outstanding (Diluted Average) of $45.0 million as of Q3 2025, which was up 294.83% from $44.6 million recorded in Q2 2025.
  • Over the past 5 years, Rapid Micro Biosystems' Shares Outstanding (Diluted Average) peaked at $45.0 million during Q3 2025, and registered a low of $641371.0 during Q1 2021.
  • Over the past 5 years, Rapid Micro Biosystems' median Shares Outstanding (Diluted Average) value was $43.0 million (recorded in 2023), while the average stood at $37.1 million.
  • In the last 5 years, Rapid Micro Biosystems' Shares Outstanding (Diluted Average) skyrocketed by 981819.09% in 2021 and then surged by 101.2% in 2024.
  • Quarter analysis of 5 years shows Rapid Micro Biosystems' Shares Outstanding (Diluted Average) stood at $19.8 million in 2021, then skyrocketed by 114.59% to $42.5 million in 2022, then increased by 1.34% to $43.0 million in 2023, then rose by 1.28% to $43.6 million in 2024, then increased by 3.17% to $45.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $45.0 million in Q3 2025, compared to $44.6 million in Q2 2025 and $44.0 million in Q1 2025.